Deputy Prime Minister of the Republic of Kazakhstan Tugzhanov Yeraly Lukpanovich, within the framework of the instructions of the Head of State Kassym-Jomart Kemelevich Tokayev on ensuring the biosafety of the country, indicated in the Message to the People of Kazakhstan, got acquainted with the work of the scientific and production enterprise “Antigen”. Currently, this company is a partner of the Research Institute of Biological Safety Problems of the Ministry of Education and Science of the Republic of Kazakhstan. RIBSP, using the Antigen site, prepared and put into operation the second production site for the full cycle of production of medical vaccines, including QazVac. For these purposes, with the support of the Akimat (local authorities) of the Almaty region, new technological equipment for the production of vaccines was purchased on preferential loans.
In September of this year, 300 thousand validation series of QazVac vaccines have already been released at the field of Antigen with a capacity of up to 1 million doses per month. International quality standards enable the company to achieve a high technical level, quality and reliability in all areas of production. SPE “Antigen”, along with the biopharmaceutical plant at OtarBioPharm LLP, became the second production site for the production of Kazakhstan’s QazVac vaccine developed by RIBSP.